









市场行情
/
股票
/
nasdaq-bsx
/

波士顿科学

BSX

91.924USD

-0.656-0.71%

交易中（美东）报价延迟15分钟

136.26B总市值

48.69市盈率 TTM



波士顿科学

91.924

-0.656-0.71%

概览公司财务分析

概览

公司

财务

分析

关于波士顿科学公司

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

波士顿科学简介



公司代码BSX

公司名称Boston Scientific Corp

上市日期May 19, 1992

CEOMahoney (Michael F)

员工数量53000

证券类型Ordinary Share

年结日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编01752-1234

电话15086834000

网址https://www.bostonscientific.com/en-US/Home.html

公司代码BSX

上市日期May 19, 1992

CEOMahoney (Michael F)

波士顿科学公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

Mr. Edward J. Ludwig

Lead Independent Director

名称

名称/职务

职务

持股

持股变动

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

其他

1.38B

27.25%

地区USD

名称

营收

占比

United States

3.22B

63.70%

EMEA (Europe, Middle East and Africa)

878.00M

17.35%

Asia Pacific

790.00M

15.61%

Latin America and Canada

169.00M

3.34%

业务

地区

业务USD

名称

营收

占比

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

其他

1.38B

27.25%

股东统计

更新时间: 11月8日周六

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

其他

72.63%

持股股东

占比

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

其他

72.63%

股东类型

持股股东

占比

Investment Advisor

50.76%

Investment Advisor/Hedge Fund

29.08%

Hedge Fund

4.91%

Pension Fund

2.94%

Research Firm

2.73%

Bank and Trust

1.89%

Sovereign Wealth Fund

1.58%

Family Office

0.23%

Private Equity

0.18%

其他

5.69%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

2858

1.40B

94.34%

-402.85K

2025Q3

2905

1.40B

94.56%

+9.92M

2025Q2

2818

1.39B

94.08%

+7.87M

2025Q1

2724

1.38B

93.98%

-8.23M

2024Q4

2559

1.38B

93.68%

+12.79M

2024Q3

2401

1.36B

94.13%

-3.01M

2024Q2

2325

1.37B

94.20%

+2.64M

2024Q1

2212

1.37B

95.15%

-32.63M

2023Q4

2153

1.38B

96.34%

-8.17M

2023Q3

2083

1.39B

95.41%

+17.41M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

136.47M

9.21%

+2.53M

+1.89%

Jun 30, 2025

Fidelity Management & Research Company LLC

99.47M

6.71%

-17.98M

-15.31%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

78.19M

5.28%

+380.40K

+0.49%

Jun 30, 2025

State Street Investment Management (US)

65.19M

4.4%

+713.38K

+1.11%

Jun 30, 2025

PRIMECAP Management Company

34.66M

2.34%

-1.83M

-5.03%

Jun 30, 2025

Geode Capital Management, L.L.C.

32.42M

2.19%

+622.60K

+1.96%

Jun 30, 2025

Capital World Investors

28.52M

1.93%

-33.95K

-0.12%

Jun 30, 2025

Managed Account Advisors LLC

22.05M

1.49%

+765.61K

+3.60%

Jun 30, 2025

The Bollard Group, LLC

20.08M

1.36%

-411.38K

-2.01%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

19.46M

1.31%

-275.11K

-1.39%

Jun 30, 2025

持股ETF



更新时间: 12月1日周一

机构名称

占比

iShares U.S. Medical Devices ETF

12.15%

Goldman Sachs Future Health Care Equity ETF

8.33%

Invesco Dorsey Wright Healthcare Momentum ETF

3.87%

Tema Heart & Health ETF

3.66%

First Trust Bloomberg R&D Leaders ETF

3.14%

Parnassus Core Select ETF

3.1%

WisdomTree US AI Enhanced Value Fund

3.1%

Health Care Select Sector SPDR Fund

3.06%

Global X Aging Population ETF

2.99%

Proshares Ultra Health Care

2.95%

iShares U.S. Medical Devices ETF

占比12.15%

Goldman Sachs Future Health Care Equity ETF

占比8.33%

Invesco Dorsey Wright Healthcare Momentum ETF

占比3.87%

Tema Heart & Health ETF

占比3.66%

First Trust Bloomberg R&D Leaders ETF

占比3.14%

Parnassus Core Select ETF

占比3.1%

WisdomTree US AI Enhanced Value Fund

占比3.1%

Health Care Select Sector SPDR Fund

占比3.06%

Global X Aging Population ETF

占比2.99%

Proshares Ultra Health Care

占比2.95%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

波士顿科学的前五大股东是谁？



波士顿科学的前五大股东如下：
The Vanguard Group, Inc.持有股份：136.47M，占总股份比例：9.21%。
Fidelity Management & Research Company LLC持有股份：99.47M，占总股份比例：6.71%。
BlackRock Institutional Trust Company, N.A.持有股份：78.19M，占总股份比例：5.28%。
State Street Investment Management (US)持有股份：65.19M，占总股份比例：4.40%。
PRIMECAP Management Company持有股份：34.66M，占总股份比例：2.34%。